Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Coronavirus disease 2019 (COVID-19) is a significant viral illness with notable cardiovascular effects.
• Heart failure (HF) is a primary cause of cardiovascular mortality, raising concerns about COVID-19's impact on HF patients.
• The pandemic necessitated healthcare system changes, including virtual clinics and revised critical care triage.

Purpose of the Study:

• To review the cardiovascular implications of COVID-19.
• To explore new telehealth practices for monitoring and triaging heart failure patients.
• To discuss current medical society guidelines, the role of ACE inhibitors, and advanced HF management.

Main Methods:

• Literature review focusing on cardiovascular manifestations of COVID-19.
• Analysis of telehealth applications in heart failure management.
• Discussion of established medical practices and pharmacological roles.

Main Results:

• COVID-19 presents significant cardiovascular challenges, particularly for patients with pre-existing heart failure.
• Telehealth has emerged as a crucial tool for managing and triaging HF patients remotely.
• Established guidelines and specific medications like ACE inhibitors remain relevant in the context of COVID-19.

Conclusions:

• Understanding COVID-19's cardiovascular impact is vital for effective patient management.
• Telehealth integration offers a sustainable solution for ongoing heart failure care.
• A multidisciplinary approach is essential for managing advanced heart failure during and after the pandemic.